Loading...
The place of ARBs in heart failure therapy: is aldosterone suppression the key?
Since the launch of the first orally available angiotensin II (AngII) type 1 receptor (AT(1)R) blocker (ARB) losartan (Cozaar) in the late 1990s, the class of ARBs (or ‘sartans’, short for Angiotensin-RecepTor-ANtagonistS) quickly expanded to include candesartan, eprosartan, irbesartan, valsartan, t...
Na minha lista:
| Udgivet i: | Ther Adv Cardiovasc Dis |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6691655/ https://ncbi.nlm.nih.gov/pubmed/31401939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944719868134 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|